Scientists from Stockholm University in Sweden have developed a method for screening and determining drugs in human saliva using microextraction by packed sorbent (MEPS) and liquid chromatography tandem mass spectrometry (LC?MS?MS).1
Scientists from Stockholm University in Sweden have developed a method for screening and determining drugs in human saliva using microextraction by packed sorbent (MEPS) and liquid chromatography tandem mass spectrometry (LC–MS–MS).1
Traditionally, blood, plasma, and urine are used in drug studies in clinical and preclinical settings. Saliva, on the other hand, offers a non-invasive alternative to these traditional options. A range of drugs and their metabolites can be found in different concentrations in saliva. Lead author, Mohamed Abdel-Rehim, told The Column: “I was interested in this area for some years ago since I know many people (one of them is my son) are scared when they give blood samples. I became interested in saliva because saliva offers fast and non-invasive sampling. The collection and storage of saliva is also easier than blood.”
MEPS is a miniaturized sample preparation technique invented by Abdel-Rehim, and has been used to extract a wide range of drugs. In this study, published in Biomedical Chromatography, the team used lidocaine, a common local anesthetic, as the drug they extracted from saliva. A sample of 500 mg lidocaine salve was applied topically to the skin and saliva samples were collected at 0 h, 1 h, 1.5 h, 2 h, 3 h, and 4 h. The samples were then passed through the MEPS sorbent and analysed by LC–MS–MS.
The team was able to collect an exact volume of saliva at each attempt and high throughput was achieved. When the results were compared with those obtained from plasma, they were found to be similar. The only difference was that the concentration levels were lower in saliva than plasma. The method was regarded as cost-effective because the MEPS sorbent could be used more than 50 times before it was disposed of.
It was concluded that the study was suitable for automation and the small sample collections makes it ideal to obtain samples from children. Abdel-Rehim added: “The use of oral fluids as drug testing and as [a] diagnostic tool will be investigated in future work.”
Reference
1. A. Abdel-Rehim and M. Abdel-Rehim, Biomedical Chromatography DOI:10.1002/bmc.2925 (2013).
This story originally appeared in The Column. Click here to view that issue.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.